Curative Health Insurance Company just closed a $150M Series B that pushes its valuation to $1.275B and confirms that its model is working at scale. The round is led by Upside Vision Fund, with Justin Mateen personally adding $47.5M on top of an early investment that has already appreciated more than 400x, which signals deep conviction in Curative’s trajectory.
From its origin in 2020, Curative evolved from a rapid scale COVID testing and vaccination operation into a health insurance company focused on aligning incentives around prevention and outcomes rather than denial and complexity. Under founder Fred Turner, the company scaled from a small diagnostics team to delivering over 36M tests and millions of vaccinations, then redirected that operational and technical capability into insurance. Co-founder Dr. Isaac Turner built the data and engineering systems to handle national-scale workloads, while Tami Wilson Ciranna established the financial and operational structure and now serves as President and Co-Founder as Curative focuses on insurance.
Curative’s health plan now serves 65,000+ members across over 1,200 employers in Texas, Florida, and Georgia, with Maryland and Washington, DC next in line. Performance metrics show very high engagement and impact, baseline preventive “visit” completion around 98%, ongoing engagement around 94%, and meaningful reductions in hospitalizations and drug costs alongside adherence rates in the mid-90% range for chronic conditions like diabetes and hypertension. These metrics indicate the model is driving both clinical and cost improvements rather than just shifting risk.
A key differentiator is the Curative Cash Card, which lets members access over one million providers and pays the provider at the point of service, aiming to eliminate surprise billing and long reimbursement cycles. This payment model is designed to simplify member experience and administrative processes, presenting insurance as a real-time, predictable benefit. The company has also reached profitability much earlier than is typical in health insurance, suggesting its unit economics support scaling.
The new capital is positioned as fuel to expand Curative’s geographic reach and employer footprint while reinforcing its technology, care navigation, and member-experience infrastructure. If Curative maintains current performance and expansion, its approach may pressure traditional carriers to adopt similar aligned-incentive models or risk looking outdated in both cost and user experience.
Startups Startup Funding Venture Capital Series B Healthcare Health Tech Health Insurance Insurance Insurance Tech Data Data Driven Infrastructure Technology Innovation Tech Ecosystem Startup Ecosystem Hiring Tech Hiring
